GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells

Regulatory Peptides

Volumn 109, Issue 1-3, 2002, Pages 141-148

  Xiao, Dongmei ^a   Qu, Xiangping ^a   Weber, H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin; c fos; c jun; c myc; Ets transcription factor; Mitogen

Indexed keywords

ANDROGEN; BOMBESIN; GASTRIN RELEASING PEPTIDE; GENE PRODUCT; MESSENGER RNA; MYC PROTEIN; PROTEIN C FOS; PROTEIN C JUN; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA;

BOMBESIN; CELL DIVISION; DNA; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, BOMBESIN; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

CERVUS ELAPHUS; MAMMALIA;

EID: 0037111343     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00197-0     Document Type: Article

References (47)

1. Kroog G.S., Jensen R.T., Battey J.F. Mammalian bombesin receptors. Med. Res. Rev. 15:1995;389-417.
2. Cuttitta F., Carney D.N., Mulshine J., Moody T.W., Fedorko J., Fischler A.et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 316:1985;823-826.
3. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J. Cell. Physiol. 177:1998;507-517.
4. Rozengurt E., Sinnett-Smith J. Early signals underlying the induction of the c-fos and c-myc genes in quiescent fibroblasts: studies with bombesin and other growth factors. Prog. Nucleic Acid Res. Mol. Biol. 35:1988;261-295.
5. Rozengurt E., Sinnett-Smith J.W. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response. J. Cell. Physiol. 131:1987;218-225.
6. Rozengurt E., Sinnett-Smith J. Bombesin stimulation of fibroblast mitogenesis: specific receptors, signal transduction and early events. Philos. Trans. R. Soc. Lond., B Biol. Sci. 327:1990;209-221.
7. Palumbo A.P., Rossino P., Comoglio P.M. Bombesin stimulation of c-fos and c-myc gene expression in cultures of Swiss 3T3 cells. Exp. Cell Res. 167:1986;276-280.
8. Burghardt B., Wenger C., Barabas K., Racz G., Olah A., Flautner L.et al. GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF. Peptides. 22:2001;1119-1128.
9. Bravo R., Macdonald-Bravo H., Muller R., Hubsch D., Almendral J.M. Bombesin induces c-fos and c-myc expression in quiescent Swiss 3T3 cells. Comparative study with other mitogens. Exp. Cell Res. 170:1987;103-115.
10. Mehmet H., Millar J.B., Lehmann W., Higgins T., Rozengurt E. Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: the role of prostaglandin E2-mediated cyclic AMP accumulation. Exp. Cell Res. 190:1990;265-270.
11. Draoui M., Chung P., Park M., Birrer M., Jakowlew S., Moody T.W. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides. 16:1995;289-292.
12. Chatzistamou I., Schally A.V., Sun B., Armatis P., Szepeshazi K. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists. Br. J. Cancer. 83:2000;906-913.
13. Bologna M., Festuccia C., Muzi P., Biordi L., Ciomei M. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer. 63:1989;1714-1720.
14. Jungwirth A., Galvan G., Pinski J., Halmos G., Szepeshazi K., Cai R.Z.et al. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate. 32:1997;164-172.
15. Jungwirth A., Pinski J., Galvan G., Halmos G., Szepeshazi K., Cai R.Z.et al. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur. J. Cancer. 33:1997;1141-1148.
16. Pinski J., Halmos G., Schally A.V. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett. 71:1993;189-196.
17. Plonowski A., Nagy A., Schally A.V., Sun B., Groot K., Halmos G. In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215. Int. J. Cancer. 88:2000;652-657.
18. Plonowski A., Schally A.V., Varga J.L., Rekasi Z., Hebert F., Halmos G.et al. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways. Prostate. 44:2000;172-180.
19. Sun B., Halmos G., Schally A.V., Wang X., Martinez M. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate. 42:2000;295-303.
20. Xiao D., Wang J., Hampton L., Weber H.C. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene. 264:2001;95-103.
21. Markwalder R., Reubi J.C. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 59:1999;1152-1159.
22. Bartholdi M.F., Wu J.M., Pu H., Troncoso P., Eden P.A., Feldman R.I. In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. Int. J. Cancer. 79:1998;82-90.
23. Landis S.H.M.T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 49:1999;8-31.
24. Aprikian A.G., Han K., Chevalier S., Bazinet M., Viallet J. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J. Mol. Endocrinol. 16:1996;297-306.
25. Larran J., Salido M., Aparicio J., Lopez A., de Palacio M.L., Vilches J. In vitro characterization of bombesin and calcitonin on the proliferation of PC3, DU 145 and LNCaP cancer prostatic cell lines. Int. J. Dev. Biol. 1996;16:275S-276S. [Suppl.].
26. Wasilenko W.J., Cooper J., Palad A.J., Somers K.D., Blackmore P.F., Rhim J.S.et al. Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate. 30:1997;167-173.
27. Reile H., Armatis P.E., Schally A.V. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Prostate. 25:1994;29-38.
28. Yordy J.S., Muise-Helmericks R.C. Signal transduction and the Ets family of transcription factors. Oncogene. 19:2000;6503-6513.
29. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev., Mol. Cell Biol. 2:2001;827-837.
30. Sementchenko V.I., Watson D.K. Ets target genes: past, present and future. Oncogene. 19:2000;6533-6548.
31. Mimeault M. Structure-function studies of ETS transcription factors. Crit. Rev. Oncog. 11:2000;227-253.
32. Abrahamsson P.A. Neuroendocrine cells in tumour growth of the prostate. Endocr. Relat. Cancer. 6:1999;503-519.
33. Abrahamsson P.A. Neuroendocrine differentiation and hormone-refractory prostate cancer. Prostate, Suppl. 6:1996;3-8.
34. Abrahamsson P.A. Neuroendocrine differentiation in prostatic carcinoma. Prostate. 39:1999;135-148.
35. Aprikian A.G., Han K., Guy L., Landry F., Begin L.R., Chevalier S. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer. Prostate, Suppl. 8:1998;52-61.
36. di Sant'Agnese P.A. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects. Urology. 51:1998;121-124.
37. di Sant'Agnese P.A. Neuroendocrine differentiation in prostatic carcinoma: an update. Prostate, Suppl. 8:1998;74-79.
38. di Sant'Agnese P.A., Cockett A.T. Neuroendocrine differentiation in prostatic malignancy. Cancer. 78:1996;357-361.
39. Aprikian A.G., Tremblay L., Han K., Chevalier S. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int. J. Cancer. 72:1997;498-504.
40. Bold R.J., Lowry P.S., Ishizuka J., Battey J.F., Townsend C.M., Thompson J.C. Bombesin stimulates the in vitro growth of a human gastric cancer cell line. J. Cell. Physiol. 161:1994;519-525.
41. Mehmet H., Morris C., Rozengurt E. Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP. Cell Growth Differ. 1:1990;293-298.
42. Rozengurt E. Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events. Am. Rev. Respir. Dis. 142:1990;S11-S15.
43. Weber H.C., Walters J., Leyton J., Casibang M., Purdom S., Jensen R.T.et al. A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells. Eur. J. Pharmacol. 412:2001;13-20.
44. Hoosein N.M., Logothetis C.J., Chung L.W. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149:1993;1209-1213.
45. Koh S.W., Leyton J., Moody T.W. Bombesin activates MAP kinase in non-small cell lung cancer cells. Peptides. 20:1999;121-126.
46. Jessie English G.P., Wilsbacher J., Swantek J., Karandikar M., Xu S., Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell Res. 253:1999;255-270.
47. Gutkind J.S. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci. STKE. 2000;40.